Chapitre 3 : Prise en charge médicale de la douleur associée à l'endométriose
article
OA: bronze
CC0
AI-generated summary
This chapter reviews the medical management of pain associated with endometriosis, discussing various pharmacological and non-pharmacological treatment options.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (42)
- Action of danazol on plasma lipids and lipoprotein metabolism. via openalex
- Add-back therapy in the treatment of endometriosis-associated pain via openalex
- A levonorgestrel-releasing intrauterine system for the treatment of dysmenorrhea associated with endometriosis: a pilot study via openalex
- Anastrazole and oral contraceptives: a novel treatment for endometriosis via openalex
- Chocolate cysts from ovarian follicles via openalex
- Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen via openalex
- Danazol—a Synthetic Steroid Derivative with Interesting Physiologic Properties via openalex
- Danazol for pelvic pain associated with endometriosis via openalex
- Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis—a randomized, double-blind, multicenter, controlled trial via openalex
- Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study via openalex
- Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile via openalex
- Does Response to Hormonal Therapy Predict Presence or Absence of Endometriosis? via openalex
- Effect of norethindrone acetate in the treatment of symptomatic endometriosis. via openalex
- Efficacy of vaginal danazol treatment in women with recurrent deeply infiltrating endometriosis via openalex
- Endometriosis via openalex
- Endometriosis and its treatment with danazol or lupron in relation to ovarian cancer. via openalex
- Estrogen biosynthesis in endometriosis: molecular basis and clinical relevance via openalex
- Hormone treatment of endometriosis: The estrogenthreshold hypothesis via openalex
- Leuprolide Acetate Depot and Hormonal Add-Back in Endometriosis: A 12-Month Study via openalex
- Long-term follow-up of a controlled trial of laser laparoscopy for pelvic pain. via openalex
- Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial via openalex
- Prevention of bone loss and hypoestrogenic symptoms by estrogen and interrupted progestogen add-back in long-term GnRH-agonist down-regulated patients with endometriosis and premenstrual syndrome via openalex
- Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: long-term follow-up*1 via openalex
- Prospective, randomized, double-blind, controlled trial of laser laparoscopy in the treatment of pelvic pain associated with minimal, mild, and moderate endometriosis via openalex
- Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain via openalex
- Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain via openalex
- The effects and effectiveness of laparoscopic excision of endometriosis: a prospective study with 2-5 year follow-up via openalex
- Treatment with leuprolide acetate and hormonal add-back for up to 10 years in stage IV endometriosis patients with chronic pelvic pain via openalex
- Use of a levonorgestrel-releasing intrauterine device in the treatment of rectovaginal endometriosis via openalex
- W2159803441 via openalex
- W2074845402 via openalex
- W2019272525 via openalex
- W2010311608 via openalex
- W1990697327 via openalex
- W1969539871 via openalex
- W6672127118 via openalex
- W6683952698 via openalex
- W6715458637 via openalex
- W6716955854 via openalex
- W6824378097 via openalex
- W2123134517 via openalex
- W2101417341 via openalex
Source provenance
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0
· commercial use OK